MERCK & CO

NJ

A research-intensive biopharmaceutical company

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 8 of its records are shown together here.

Filings
154
Filed By
8
Reported In-House
—
Reported By Firms
$6,085,000

Filings

YearFirmPeriodAmountDoc
2020 TARPLIN, DOWNS & YOUNG, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
2020 FORBES-TATE 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2020 TARPLIN, DOWNS & YOUNG, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$60,000
2020 FORBES-TATE 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2020 TARPLIN, DOWNS & YOUNG, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2020 FORBES-TATE 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$50,000
2020 FORBES-TATE 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$50,000
2020 TARPLIN, DOWNS & YOUNG, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$60,000
Filed By
Issue Areas

Bills Mentioned in Filings